Side Effects of Melanotan II: What the Evidence Shows

Melanotan II's most commonly reported side effects are nausea, facial flushing, headache, fatigue, and new or darkened moles. More serious reactions include priapism (a prolonged, painful erection), blood pressure and heart rate changes, and injection-site infections. The peptide is not FDA-approved for human use, and no large human trial has established its long-term safety profile.

What Melanotan II Is and How It's Used

Melanotan II is a synthetic peptide modeled on alpha-melanocyte-stimulating hormone (a-MSH), the body's natural signal for melanin production. It was developed in the 1980s by researchers studying sunless tanning and pigment disorders, and it was never approved as a prescription drug.

Today it is sold online as a "tanning peptide" or "research chemical," usually as a powder that users mix and inject under the skin. Because these products are marketed for research rather than human use, no manufacturer is required to report purity, dose accuracy, or adverse events.

Common Side Effects of Melanotan II

Most user reports describe effects beginning 30 to 90 minutes after an injection and fading over several hours. Dose, injection frequency, and individual sensitivity all appear to influence how strong the reaction is.

• Nausea and vomiting: Often the first thing users notice, sometimes within minutes of injecting.
• Facial flushing and warmth: A sudden red, hot feeling across the face, neck, and chest.
• Headache and dizziness: Frequently accompanied by lightheadedness when standing up quickly.
• Fatigue and lethargy: Many users report drowsiness in the hours after a dose.
• Appetite loss: Melanocortin receptors affect satiety, so reduced hunger is a common complaint.
• Injection-site reactions: Redness, pain, swelling, or firm lumps under the skin.
• Skin changes: Darkening of existing moles and freckles, new freckles, and darker lips, gums, or nipples.
• Spontaneous yawning and stretching: An unusual but consistently reported effect linked to melanocortin activity in the brain.

Serious Side Effects and Safety Concerns

Some reactions reported with melanotan II are severe enough to require emergency care. The melanotan II safety record rests almost entirely on user anecdotes and case reports rather than controlled clinical trials, which means rare or delayed harms may not be captured at all.

Priapism and Genital Effects

Melanotan II has been studied for erectile effects, and priapism, meaning an erection lasting four hours or longer, is a documented risk. Priapism is a medical emergency that can cause permanent tissue damage and erectile dysfunction if it is not treated.

Users also describe increased libido, spontaneous erections, and genital darkening. Anyone who experiences an erection lasting more than four hours should seek emergency care immediately.

Cardiovascular and Systemic Reactions

Flushing often comes with a measurable rise in heart rate and shifts in blood pressure. Cases of severe nausea with vomiting, dehydration, and fainting have been reported, along with rare allergic reactions.

Melanoma and Pigment Cell Questions

Melanotan II stimulates melanocytes, the same cells involved in melanoma. No study has proven that the peptide causes melanoma, but the long-term risk to people who inject it repeatedly for years is unknown.

Dermatologists generally advise that rapidly darkening moles should be examined, because telling a cosmetic pigment change apart from an early melanoma is not something a user can do at home.

Side Effect Overview at a Glance

Category	Examples	Typical timing
Common	Nausea, flushing, headache, fatigue, appetite loss, injection-site redness	30 to 90 minutes after injection; resolves within hours
Less common	Darkened lips and gums, new freckles, mood changes, dizziness, yawning	Days to weeks of repeated use
Serious	Priapism, severe hypertension, fainting, infection or abscess, allergic reaction	Any time; may require emergency care
Unknown	Long-term melanoma risk, organ effects, drug interactions	Unknown, because no long-term human data exist

Melanotan II FDA Status and Legal Standing

Melanotan II is not approved by the FDA for any indication, and it is not a lawful prescription or over-the-counter drug in the United States. The FDA has issued public warnings about injectable tanning products and has seized shipments of them at the border.

The melanotan II legal picture is unusual. It is not a federally controlled substance, so simple possession is generally not a federal crime, but selling it for human consumption violates drug law because it is an unapproved new drug.

Product	FDA status	Legal to sell for human use in the US
Melanotan II	Not approved	No, it is an unapproved new drug
Melanotan I (afamelanotide / Scenesse)	Approved in 2019 for erythropoietic protoporphyria	Yes, prescription only
Tanning injections sold online	Unapproved and often mislabeled	No

Melanotan I is FDA-approved as a prescription implant for a rare light-sensitivity disorder, not for tanning, and it is dispensed only under medical supervision.

Why Unregulated Supply Adds Risk

Because melanotan II is sold outside the regulated supply chain, buyers have no way to verify what is in the vial. Independent testing of research peptides has repeatedly found underdosed or overdosed vials, bacterial contamination, and compounds that differ entirely from the label.

Users also self-dose, often without knowing the concentration they have mixed, and an accidental overdose can intensify nausea, blood pressure swings, and other reactions.

This supply problem is not unique to tanning peptides. People looking into other injectables often review side effects of cjc 1295 and ipamorelin or read up on side effects of ipamorelin peptide, and the same purity concerns apply to those products. Similar questions come up around side effects of lipo c injections and side effects of glutathione injections, since those items are also sold largely outside regulated pharmacy channels.

By contrast, long-studied oral supplements have better-documented profiles. For example, side effects of l-carnitine are generally limited to stomach upset or a fishy body odor at high doses.

What to Do If You're Considering Melanotan II

There is no supervised, legal way to use melanotan II for tanning in the United States, because no clinician can prescribe it for that purpose and no pharmacy-grade version exists.

• Talk to a dermatologist or primary care provider about tanning goals and skin cancer risk instead.
• If you already inject it, stop and tell a healthcare professional, especially before surgery or new medications.
• Seek emergency care for an erection lasting four hours, chest pain, fainting, or signs of infection at an injection site.
• Have any new or rapidly changing mole checked by a dermatologist.

The Bottom Line

Melanotan II can cause nausea, flushing, headaches, fatigue, and lasting pigment changes, and it carries a documented risk of priapism and other serious reactions. The peptide is not FDA-approved, is illegal to sell for human use in the United States, and has no established long-term safety data.

Anyone weighing the side effects of melanotan II against a cosmetic tan should also weigh the fact that the product is unregulated, unapproved, and impossible to dose with certainty.

COMMON QUESTIONS

Frequently Asked Questions

Is melanotan II FDA approved?

No. Melanotan II is not approved by the FDA for any human use, including tanning. It is sold online as a research chemical, which means it bypasses the safety, purity, and labeling requirements that apply to prescription drugs.

Is melanotan II legal in the United States?

Melanotan II is not a federally controlled substance, so possession is generally not a federal crime. Selling it for human consumption is illegal, however, because it is an unapproved new drug, and the FDA has warned consumers and seized shipments of injectable tanning peptides.

Can melanotan II cause melanoma?

No study has proven that melanotan II causes melanoma, but the peptide stimulates melanocytes, the cells that can become melanoma, and long-term human data are essentially nonexistent. Any new, rapidly darkening, or irregular mole should be evaluated by a dermatologist.